Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (31-40 of 222) with videos related to

Pageof 23
Sort By:
Wellcome Open Research|March 13, 2023
Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?Cori Campbell, Tingyan Wang, Rebekah Burrow, et al.
BMJ Open|October 1, 2024
Prospective cohort for early detection of liver cancer (Pearl): a study protocolKartikeya Khanna, Eleanor Barnes, Jennifer Benselin, et al.
European Journal of Immunology|September 30, 2014
Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopesChristabel Kelly, Leo Swadling, Anthony Brown, et al.
Immunology Letters|January 16, 2003
Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramersMaria Kantzanou, Michaela Lucas, Eleanor Barnes, et al.
Nature Reviews. Immunology|December 20, 2022
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responsesSam M Murray, Azim M Ansari, John Frater, et al.
Vaccine|June 14, 2020
Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopesTimothy Donnison, Annette von Delft, Anthony Brown, et al.
BMJ Open|December 1, 2022
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort studyVictoria Ward, Jia Wei, William Gordon, et al.
Hepatology (Baltimore, Md.)|July 30, 2014
Global distribution and prevalence of hepatitis C virus genotypesJane P Messina, Isla Humphreys, Abraham Flaxman, et al.
Nature Reviews. Gastroenterology & Hepatology|March 11, 2021
COVID-19 and liver disease: mechanistic and clinical perspectivesThomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
Diagnostic and Prognostic Research|October 19, 2022
Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis planWeiqi Liao, Peter Jepsen, Carol Coupland, et al.
Pageof 23

Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
Wellcome Open Research|March 13, 2023
Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?Cori Campbell, Tingyan Wang, Rebekah Burrow, et al.
BMJ Open|October 1, 2024
Prospective cohort for early detection of liver cancer (Pearl): a study protocolKartikeya Khanna, Eleanor Barnes, Jennifer Benselin, et al.
European Journal of Immunology|September 30, 2014
Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopesChristabel Kelly, Leo Swadling, Anthony Brown, et al.
Immunology Letters|January 16, 2003
Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramersMaria Kantzanou, Michaela Lucas, Eleanor Barnes, et al.
Nature Reviews. Immunology|December 20, 2022
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responsesSam M Murray, Azim M Ansari, John Frater, et al.
Vaccine|June 14, 2020
Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopesTimothy Donnison, Annette von Delft, Anthony Brown, et al.
BMJ Open|December 1, 2022
SARS-CoV-2 antibody responses post-vaccination in UK healthcare workers with pre-existing medical conditions: a cohort studyVictoria Ward, Jia Wei, William Gordon, et al.
Hepatology (Baltimore, Md.)|July 30, 2014
Global distribution and prevalence of hepatitis C virus genotypesJane P Messina, Isla Humphreys, Abraham Flaxman, et al.
Nature Reviews. Gastroenterology & Hepatology|March 11, 2021
COVID-19 and liver disease: mechanistic and clinical perspectivesThomas Marjot, Gwilym J Webb, Alfred S Barritt, et al.
Diagnostic and Prognostic Research|October 19, 2022
Development and validation of personalised risk prediction models for early detection and diagnosis of primary liver cancer among the English primary care population using the QResearch® database: research protocol and statistical analysis planWeiqi Liao, Peter Jepsen, Carol Coupland, et al.
Pageof 23